Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jialin Xiang

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Plos Genetics|December 18, 2025
Circular RNA profiling revealed an evolutionarily conserved circACACA promotes liver lipid metabolism, oxidative stress, and autophagy disorder in a ceRNA mannerJing Zhao, Shunshun Han, Jialin Xiang, et al.
Frontiers in Psychiatry|November 3, 2025
Multimodal MRI study of gray matter and functional connectivity abnormalities in adolescents with bipolar disorderPengyu Zhu, Yuxi Wang, Jialin Xiang, et al.
Clinical Nuclear Medicine|May 5, 2025
Bisphosphonate Bone Imaging Agent [68Ga]Ga-P15-041 for Evaluating Skeletal Metastases in Prostate Cancer: A Comparison With [68Ga]Ga-PSMA-11 PET/CTJiarou Wang, Linlin Li, Tianrui Feng, et al.
Nucleic Acids Research|March 3, 2023
A virus-borne DNA damage signaling pathway controls the lysogeny-induction switch in a group of temperate pleolipovirusesZhao Chen, Ying Liu, Yixuan Wang, et al.
Molecular Pharmaceutics|December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Clinical Nuclear Medicine|April 6, 2026
Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDGJialin Xiang, Yanwei Wang, Xin Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2024
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-NOTA-RM26 and [<sup>18</sup>F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective StudyRongxi Wang, Weiming Kang, Zhen Liu, et al.
Journal of Medical Virology|February 2, 2024
Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infectionNingqing Zhang, Zuyi Chen, Meirong Huang, et al.
Acta Pharmaceutica Sinica. B|April 3, 2025
Safety, pharmacokinetics, and dosimetry of <sup>177</sup>Lu-AB-3PRGD2 in patients with advanced integrin <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub>-positive tumors: A first-in-human studyHuimin Sui, Feng Guo, Hongfei Liu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 25, 2026
Transdiagnostic mapping of common and specific regional homogeneity alterations across affective and psychotic disordersJialin Xiang, Junni Ran, Pengyu Zhu, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos Genetics|December 18, 2025
Circular RNA profiling revealed an evolutionarily conserved circACACA promotes liver lipid metabolism, oxidative stress, and autophagy disorder in a ceRNA mannerJing Zhao, Shunshun Han, Jialin Xiang, et al.
Frontiers in Psychiatry|November 3, 2025
Multimodal MRI study of gray matter and functional connectivity abnormalities in adolescents with bipolar disorderPengyu Zhu, Yuxi Wang, Jialin Xiang, et al.
Clinical Nuclear Medicine|May 5, 2025
Bisphosphonate Bone Imaging Agent [68Ga]Ga-P15-041 for Evaluating Skeletal Metastases in Prostate Cancer: A Comparison With [68Ga]Ga-PSMA-11 PET/CTJiarou Wang, Linlin Li, Tianrui Feng, et al.
Nucleic Acids Research|March 3, 2023
A virus-borne DNA damage signaling pathway controls the lysogeny-induction switch in a group of temperate pleolipovirusesZhao Chen, Ying Liu, Yixuan Wang, et al.
Molecular Pharmaceutics|December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Clinical Nuclear Medicine|April 6, 2026
Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDGJialin Xiang, Yanwei Wang, Xin Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2024
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-NOTA-RM26 and [<sup>18</sup>F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective StudyRongxi Wang, Weiming Kang, Zhen Liu, et al.
Journal of Medical Virology|February 2, 2024
Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infectionNingqing Zhang, Zuyi Chen, Meirong Huang, et al.
Acta Pharmaceutica Sinica. B|April 3, 2025
Safety, pharmacokinetics, and dosimetry of <sup>177</sup>Lu-AB-3PRGD2 in patients with advanced integrin <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub>-positive tumors: A first-in-human studyHuimin Sui, Feng Guo, Hongfei Liu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 25, 2026
Transdiagnostic mapping of common and specific regional homogeneity alterations across affective and psychotic disordersJialin Xiang, Junni Ran, Pengyu Zhu, et al.
Pageof 4